ENGETACT :ENGINEERING GENE-BASED NANOPARTICLES : A COMPUTER-AIDED STUDY TOWARD TARGETED CANCER THERAPEUTICS



Ref.No: 61505000
Start date: 19.10.2018
End date: 31.10.2021
Approval date: 19.10.2018
Department: CHEMICAL ENGINEERING
Sector: MATERIALS SCIENCE AND ENGINEERING
Financier: 1η ΠΡΟΚΗΡΥΞΗ ΕΛΙΔΕΚ ΓΙΑ ΕΝΙΣΧΥΣΗ ΜΕΤΑΔΙΔ. ΕΡΕΥΝΗΤΩΝ, ELIDEK/GGET
Budget: 119.500,00 €
Public key: 6Υ7646ΨΖΣ4-3ΓΩ
Scientific Responsible: Prof. GEORGIOS PAPADOPOULOS , EVANGELIA PANTATOSAKI
Email: gkpap@chemeng.ntua.gr,evpanta@chemeng.ntua.gr
Description: THE MOST PROMISING TARGETED THERAPEUTIC AGENTS ARE SYNTHETIC FRAGMENTS OF GENETIC MATERIAL, WHICH WHEN DELIVERED INSIDE OF CANCER CELLS THEY TRIGGER AN ENDOGENOUS CELLULAR PROCESS AND SILENCE THE EXPRESSION OF THE PATHOGENIC GENES THAT CONTROL THE....
Go to Top